<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://m2.mtmt.hu/xsl/gui3.xsl" ?>
<myciteResult>
  <serverUrl>https://m2.mtmt.hu/</serverUrl>
  <labelLang>hun</labelLang>
  <responseDate>2026-09-22 19:06</responseDate>
  <content>
    <publication>
      <otype>JournalArticle</otype>
      <mtid>34076543</mtid>
      <status>VALIDATED</status>
      <published>true</published>
      <comment>Laboratory of Functional Genomics, Biological Research Centre, Temesvári krt. 62, Szeged, H6726, Hungary            
            Department of Physiology, Anatomy and Neuroscience, Faculty of Science and Informatics, University of Szeged, Közép fasor 52, Szeged, H6726, Hungary            
            CS-Smartlab Devices Ltd., Ady E. u. 14, Kozármisleny, H7761, Hungary            
            AstridBio Technologies Ltd., Wimmer Fülöp utca 1, Szeged, H6728, Hungary            
            Avidin Ltd, Alsó Kikötő sor 11/D, Szeged, H6726, Hungary            
            Department of Pathology, University of Szeged, Állomás u. 2, Szeged, H6725, Hungary            
            Export Date: 20 October 2023            
            Correspondence Address: Szebeni, G.J.; Laboratory of Functional Genomics, Temesvári krt. 62, Hungary; email: szebeni.gabor@brc.hu            
            Correspondence Address: Puskás, L.G.; Laboratory of Functional Genomics, Temesvári krt. 62, Hungary; email: laszlo@avidinbiotech.com            
            Chemicals/CAS: cyclophosphamide, 50-18-0, 6055-19-2; immunoglobulin G, 97794-27-9, 308067-58-5; interleukin 2, 85898-30-2; propidium iodide, 25535-16-4; resazurin, 550-82-3; streptomycin, 57-92-1            
            Manufacturers: Thermo, United States            
            Funding details: Magyar Tudományos Akadémia, MTA, BO/00582/22/8            
            Funding details: Nemzeti Kutatási Fejlesztési és Innovációs Hivatal, NKFIH            
            Funding details: National Research, Development and Innovation Office            
            Funding text 1: This research was funded by the 2020-1.1.6-JÖVŐ−2021-00003 and 142877 FK22 grants from the National Research, Development, and Innovation Office (NKFI), Hungary. This work was supported by the János Bolyai Research Scholarship of the Hungarian Academy of Sciences BO/00582/22/8 (GJS).</comment>
      <unhandledTickets>0</unhandledTickets>
      <deleted>false</deleted>
      <lastRefresh>2026-08-31T07:11:01.409+0000</lastRefresh>
      <lastModified>2023-10-20T12:47:27.132+0000</lastModified>
      <created>2023-07-26T09:26:07.196+0000</created>
      <creator>
        <snippet>true</snippet>
        <mtid>10000561</mtid>
        <familyName>Frank</familyName>
        <givenName>Éva</givenName>
        <link>/api/author/10000561</link>
        <otype>Author</otype>
        <label>Frank Éva (szintetikus szerves kémia, szteroidkémia)</label>
        <published>true</published>
        <oldId>10000561</oldId>
      </creator>
      <lastDuplumSearch>2025-01-08T09:54:02.777+0000</lastDuplumSearch>
      <validated>2023-10-20T12:47:27.370+0000</validated>
      <validator>
        <snippet>true</snippet>
        <mtid>10073049</mtid>
        <familyName>Sóki</familyName>
        <givenName>Edina</givenName>
        <link>/api/admin/10073049</link>
        <otype>Admin</otype>
        <label>Sóki Edina (SZTE admin5)</label>
        <published>true</published>
      </validator>
      <tempLockers>
        <otype>Admin</otype>
        <mtid>10014568</mtid>
        <link>/api/admin/10014568</link>
        <label>Vándor Andrea (VA, admin)</label>
        <familyName>Vándor</familyName>
        <givenName>Andrea</givenName>
        <published>true</published>
        <oldId>10014568</oldId>
        <snippet>true</snippet>
      </tempLockers>
      <tempLocked>2024-04-03T13:51:08.797+0000</tempLocked>
      <core>true</core>
      <publicationPending>false</publicationPending>
      <type>
        <snippet>true</snippet>
        <mtid>24</mtid>
        <code>24</code>
        <link>/api/publicationtype/24</link>
        <otype>PublicationType</otype>
        <label>Folyóiratcikk</label>
        <listPosition>1</listPosition>
        <published>true</published>
        <oldId>24</oldId>
        <otypeName>JournalArticle</otypeName>
      </type>
      <subType>
        <snippet>true</snippet>
        <mtid>10000059</mtid>
        <nameEng>Article</nameEng>
        <docType>
          <snippet>true</snippet>
          <mtid>24</mtid>
          <code>24</code>
          <link>/api/publicationtype/24</link>
          <otype>PublicationType</otype>
          <label>Folyóiratcikk</label>
          <listPosition>1</listPosition>
          <published>true</published>
          <oldId>24</oldId>
          <otypeName>JournalArticle</otypeName>
        </docType>
        <link>/api/subtype/10000059</link>
        <name>Szakcikk</name>
        <otype>SubType</otype>
        <label>Szakcikk (Folyóiratcikk)</label>
        <listPosition>101</listPosition>
        <published>true</published>
        <oldId>10000059</oldId>
      </subType>
      <category>
        <snippet>true</snippet>
        <mtid>1</mtid>
        <link>/api/category/1</link>
        <otype>Category</otype>
        <label>Tudományos</label>
        <published>true</published>
        <oldId>1</oldId>
      </category>
      <firstAuthor>Szebeni, Gábor J.</firstAuthor>
      <title>Introduction of an Ultraviolet C-Irradiated 4T1 Murine Breast Cancer Whole-Cell Vaccine Model</title>
      <journal>
        <snippet>true</snippet>
        <sciIndexed>true</sciIndexed>
        <link>/api/journal/10054162</link>
        <reviewType>REVIEWED</reviewType>
        <label>VACCINES (BASEL) 2076-393X</label>
        <published>true</published>
        <hungarian>false</hungarian>
        <oldId>10054162</oldId>
        <noIF>false</noIF>
        <mtid>10054162</mtid>
        <scopusIndexed>true</scopusIndexed>
        <eIssn>2076-393X</eIssn>
        <otype>Journal</otype>
        <lang>FOREIGN</lang>
      </journal>
      <volume>11</volume>
      <issue>7</issue>
      <internalId>1254</internalId>
      <firstPageOrInternalIdForSort>1254</firstPageOrInternalIdForSort>
      <pageLength>18</pageLength>
      <publishedYear>2023</publishedYear>
      <abstractText>The advent of immunotherapy has revolutionized cancer treatments. However, the application of immune checkpoint inhibitors may entail severe side effects, with the risk of therapeutic resistance. The generation of chimeric antigen receptor (CAR) T-cells or CAR-NK cells requires specialized molecular laboratories, is costly, and is difficult to adapt to the rapidly growing number of cancer patients. To provide a simpler but effective immune therapy, a whole-cell tumor vaccine protocol was established based on ultraviolet C (UCV)-irradiated 4T1 triple-negative breast cancer cells. The apoptosis of tumor cells after UVC irradiation was verified using resazurin and Annexin V/propidium iodide flow cytometric assays. Protective immunity was achieved in immunized BALB/c mice, showing partial remission. Adoptive transfer of splenocytes or plasma from the mice in remission showed a protective effect in the naive BALB/c mice that received a living 4T1 tumor cell injection. 4T1-specific IgG antibodies were recorded in the plasma of the mice following immunization with the whole-cell vaccine. Interleukin-2 (IL-2) and oligonucleotide 2006 (ODN2006) adjuvants were used for the transfer of splenocytes from C57BL/6 mice into cyclophosphamide-treated BALB/c mice, resulting in prolonged survival, reduced tumor growth, and remission in 33% of the cases, without the development of the graft-versus-host disease. Our approach offers a simple, cost-effective whole-cell vaccine protocol that can be administered to immunocompetent healthy organisms. The plasma or the adoptive transfer of HLA-matching immunized donor-derived leukocytes could be used as an immune cell therapy for cancer patients.</abstractText>
      <digital>true</digital>
      <printed/>
      <sourceYear>2023</sourceYear>
      <foreignEdition>true</foreignEdition>
      <foreignLanguage>true</foreignLanguage>
      <fullPublication>true</fullPublication>
      <conferencePublication>false</conferencePublication>
      <nationalOrigin>true</nationalOrigin>
      <missingAuthor>false</missingAuthor>
      <oaType>GOLD</oaType>
      <oaCheckDate>2026-08-31</oaCheckDate>
      <oaFree>true</oaFree>
      <oaLink>https://real.mtak.hu/172648</oaLink>
      <citationCount>9</citationCount>
      <citationCountUnpublished>0</citationCountUnpublished>
      <citationCountWoOther>9</citationCountWoOther>
      <independentCitCountWoOther>7</independentCitCountWoOther>
      <nationalOriginCitationCount>2</nationalOriginCitationCount>
      <foreignEditionCitationCount>9</foreignEditionCitationCount>
      <doiCitationCount>9</doiCitationCount>
      <wosCitationCount>8</wosCitationCount>
      <scopusCitationCount>9</scopusCitationCount>
      <wosScopusCitationCount>9</wosScopusCitationCount>
      <wosScopusCitationCountWoOther>9</wosScopusCitationCountWoOther>
      <wosScopusIndependentCitationCount>7</wosScopusIndependentCitationCount>
      <wosScopusIndependentCitationCountWoOther>7</wosScopusIndependentCitationCountWoOther>
      <independentCitationCount>7</independentCitationCount>
      <selfCitationCount>2</selfCitationCount>
      <unhandledCitationCount>0</unhandledCitationCount>
      <citingPubCount>9</citingPubCount>
      <independentCitingPubCount>7</independentCitingPubCount>
      <citingPubCountWoOther>9</citingPubCountWoOther>
      <independentCitingPubCountWoOther>7</independentCitingPubCountWoOther>
      <unhandledCitingPubCount>0</unhandledCitingPubCount>
      <citedPubCount>14</citedPubCount>
      <citedCount>14</citedCount>
      <pubStats>
        <types>
          <type>Folyóiratcikk</type>
          <typeEng>Journal Article</typeEng>
          <code>24</code>
          <count>9</count>
        </types>
        <types>
          <type>Könyvrészlet</type>
          <typeEng>Chapter in Book</typeEng>
          <code>25</code>
          <count>0</count>
        </types>
        <types>
          <type>Könyv</type>
          <typeEng>Book</typeEng>
          <code>23</code>
          <count>0</count>
        </types>
        <types>
          <type>Egyéb konferenciaközlemény</type>
          <typeEng>Conference paper</typeEng>
          <code>31</code>
          <count>0</count>
        </types>
        <types>
          <type>Egyéb konferenciakötet</type>
          <typeEng>Conference proceedings</typeEng>
          <code>32</code>
          <count>0</count>
        </types>
        <types>
          <type>Oltalmi formák</type>
          <typeEng>Protection forms</typeEng>
          <code>26</code>
          <count>0</count>
        </types>
        <types>
          <type>Disszertáció</type>
          <typeEng>Thesis</typeEng>
          <code>28</code>
          <count>0</count>
        </types>
        <types>
          <type>Egyéb</type>
          <typeEng>Miscellaneous</typeEng>
          <code>29</code>
          <count>0</count>
        </types>
        <types>
          <type>Alkotás</type>
          <typeEng>Achievement</typeEng>
          <code>22</code>
          <count>0</count>
        </types>
        <types>
          <type>Kutatási adat</type>
          <typeEng>Research data</typeEng>
          <code>33</code>
          <count>0</count>
        </types>
        <citationTypes>
          <type>Folyóiratcikk</type>
          <typeEng>Journal Article</typeEng>
          <code>24</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Könyvrészlet</type>
          <typeEng>Chapter in Book</typeEng>
          <code>25</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Könyv</type>
          <typeEng>Book</typeEng>
          <code>23</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Egyéb konferenciaközlemény</type>
          <typeEng>Conference paper</typeEng>
          <code>31</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Egyéb konferenciakötet</type>
          <typeEng>Conference proceedings</typeEng>
          <code>32</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Oltalmi formák</type>
          <typeEng>Protection forms</typeEng>
          <code>26</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Disszertáció</type>
          <typeEng>Thesis</typeEng>
          <code>28</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Egyéb</type>
          <typeEng>Miscellaneous</typeEng>
          <code>29</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Alkotás</type>
          <typeEng>Achievement</typeEng>
          <code>22</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Kutatási adat</type>
          <typeEng>Research data</typeEng>
          <code>33</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <years>
          <year>2024</year>
          <publicationCount>0</publicationCount>
          <citationCount>3</citationCount>
          <independentCitationCount>1</independentCitationCount>
          <citingPubCount>3</citingPubCount>
          <independentCitingPubCount>1</independentCitingPubCount>
          <oaStats/>
          <oaStats2/>
        </years>
        <years>
          <year>2025</year>
          <publicationCount>0</publicationCount>
          <citationCount>2</citationCount>
          <independentCitationCount>2</independentCitationCount>
          <citingPubCount>2</citingPubCount>
          <independentCitingPubCount>2</independentCitingPubCount>
          <oaStats/>
          <oaStats2/>
        </years>
        <years>
          <year>2026</year>
          <publicationCount>0</publicationCount>
          <citationCount>3</citationCount>
          <independentCitationCount>3</independentCitationCount>
          <citingPubCount>3</citingPubCount>
          <independentCitingPubCount>3</independentCitingPubCount>
          <oaStats/>
          <oaStats2/>
        </years>
      </pubStats>
      <ratingsForSort>Q1</ratingsForSort>
      <hasCitationDuplums>false</hasCitationDuplums>
      <importDuplum>false</importDuplum>
      <importOverwritten>false</importOverwritten>
      <importSkipped>false</importSkipped>
      <userChangeableUntil>2023-10-19T12:47:26.820+0000</userChangeableUntil>
      <directInstitutesForSort>Genetikai Intézet (HRN SZBK); Központi Laboratóriumok (HRN SZBK); Pathologiai Intézet (SZTE / SZAOK); Élettani, Szervezettani és Idegtudományi Tanszék (SZTE / TTIK / BI)</directInstitutesForSort>
      <ownerAuthorCount>6</ownerAuthorCount>
      <ownerInstituteCount>17</ownerInstituteCount>
      <directInstituteCount>4</directInstituteCount>
      <authorCount>8</authorCount>
      <contributorCount>0</contributorCount>
      <hasQualityFactor>true</hasQualityFactor>
      <tempLockerIds>10014568</tempLockerIds>
      <languages>
        <language>
          <otype>Language</otype>
          <mtid>10002</mtid>
          <link>/api/language/10002</link>
          <label>Angol</label>
          <name>Angol</name>
          <nameEng>English</nameEng>
          <published>true</published>
          <oldId>2</oldId>
          <snippet>true</snippet>
        </language>
      </languages>
      <authorships>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>109382050</mtid>
          <link>/api/authorship/109382050</link>
          <label>Szebeni, Gábor J. ✉ [Szebeni, Gábor (Immunológia), szerző] Genetikai Intézet (HRN SZBK); Központi Laboratóriumok (HRN SZBK); Élettani, Szervezettani és Idegtudományi Tanszék (SZTE / TTIK / BI)</label>
          <listPosition>1</listPosition>
          <share>0.125</share>
          <first>true</first>
          <last>false</last>
          <corresponding>true</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10025339</mtid>
            <link>/api/author/10025339</link>
            <label>Szebeni Gábor (Immunológia)</label>
            <familyName>Szebeni</familyName>
            <givenName>Gábor</givenName>
            <published>true</published>
            <oldId>10025339</oldId>
            <snippet>true</snippet>
          </author>
          <familyName>Szebeni</familyName>
          <givenName>Gábor J.</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>109382051</mtid>
          <link>/api/authorship/109382051</link>
          <label>Alföldi, Róbert</label>
          <listPosition>2</listPosition>
          <share>0.125</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <familyName>Alföldi</familyName>
          <givenName>Róbert</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>109382052</mtid>
          <link>/api/authorship/109382052</link>
          <label>Nagy, Lajos I.</label>
          <listPosition>3</listPosition>
          <share>0.125</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <familyName>Nagy</familyName>
          <givenName>Lajos I.</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>109382053</mtid>
          <link>/api/authorship/109382053</link>
          <label>Neuperger, Patrícia [Neuperger, Patricia (immunológia), szerző] Genetikai Intézet (HRN SZBK); Központi Laboratóriumok (HRN SZBK)</label>
          <listPosition>4</listPosition>
          <share>0.125</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10071441</mtid>
            <link>/api/author/10071441</link>
            <label>Neuperger Patricia (immunológia)</label>
            <familyName>Neuperger</familyName>
            <givenName>Patricia</givenName>
            <published>true</published>
            <snippet>true</snippet>
          </author>
          <familyName>Neuperger</familyName>
          <givenName>Patrícia</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>109382054</mtid>
          <link>/api/authorship/109382054</link>
          <label>Gémes, Nikolett [Gémes, Nikolett (immunológia), szerző] Genetikai Intézet (HRN SZBK); Központi Laboratóriumok (HRN SZBK)</label>
          <listPosition>5</listPosition>
          <share>0.125</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10081633</mtid>
            <link>/api/author/10081633</link>
            <label>Gémes Nikolett (immunológia)</label>
            <familyName>Gémes</familyName>
            <givenName>Nikolett</givenName>
            <published>true</published>
            <snippet>true</snippet>
          </author>
          <familyName>Gémes</familyName>
          <givenName>Nikolett</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>109382055</mtid>
          <link>/api/authorship/109382055</link>
          <label>Balog, József Á. [Balog, József Ágoston (immunológia, sejt...), szerző] Genetikai Intézet (HRN SZBK); Központi Laboratóriumok (HRN SZBK)</label>
          <listPosition>6</listPosition>
          <share>0.125</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10065273</mtid>
            <link>/api/author/10065273</link>
            <label>Balog József Ágoston (immunológia, sejtbiológia)</label>
            <familyName>Balog</familyName>
            <givenName>József Ágoston</givenName>
            <published>true</published>
            <oldId>10065273</oldId>
            <snippet>true</snippet>
          </author>
          <familyName>Balog</familyName>
          <givenName>József Á.</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>109382056</mtid>
          <link>/api/authorship/109382056</link>
          <label>Tiszlavicz, László [Tiszlavicz, László (Pathológia), szerző] Pathologiai Intézet (SZTE / SZAOK)</label>
          <listPosition>7</listPosition>
          <share>0.125</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10009640</mtid>
            <link>/api/author/10009640</link>
            <label>Tiszlavicz László (Pathológia)</label>
            <familyName>Tiszlavicz</familyName>
            <givenName>László</givenName>
            <published>true</published>
            <oldId>10009640</oldId>
            <snippet>true</snippet>
          </author>
          <familyName>Tiszlavicz</familyName>
          <givenName>László</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>109382057</mtid>
          <link>/api/authorship/109382057</link>
          <label>Puskás, László G. ✉ [Puskás, László (Molekuláris biológia), szerző] Genetikai Intézet (HRN SZBK); Központi Laboratóriumok (HRN SZBK)</label>
          <listPosition>8</listPosition>
          <share>0.125</share>
          <first>false</first>
          <last>true</last>
          <corresponding>true</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10010041</mtid>
            <link>/api/author/10010041</link>
            <label>Puskás László (Molekuláris biológia)</label>
            <familyName>Puskás</familyName>
            <givenName>László</givenName>
            <published>true</published>
            <oldId>10010041</oldId>
            <snippet>true</snippet>
          </author>
          <familyName>Puskás</familyName>
          <givenName>László G.</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
      </authorships>
      <identifiers>
        <identifier>
          <otype>PublicationIdentifier</otype>
          <mtid>24204745</mtid>
          <link>/api/publicationidentifier/24204745</link>
          <label>DOI: 10.3390/vaccines11071254</label>
          <source>
            <otype>PlainSource</otype>
            <mtid>6</mtid>
            <link>/api/publicationsource/6</link>
            <label>DOI</label>
            <type>
              <otype>PublicationSourceType</otype>
              <mtid>10001</mtid>
              <link>/api/publicationsourcetype/10001</link>
              <label>DOI</label>
              <mayHaveOa>true</mayHaveOa>
              <published>true</published>
              <snippet>true</snippet>
            </type>
            <name>DOI</name>
            <nameEng>DOI</nameEng>
            <linkPattern>https://doi.org/@@@</linkPattern>
            <publiclyVisible>true</publiclyVisible>
            <published>true</published>
            <oldId>6</oldId>
            <snippet>true</snippet>
          </source>
          <validState>IDENTICAL</validState>
          <idValue>10.3390/vaccines11071254</idValue>
          <realUrl>https://doi.org/10.3390/vaccines11071254</realUrl>
          <published>false</published>
          <snippet>true</snippet>
        </identifier>
        <identifier>
          <otype>PublicationIdentifier</otype>
          <mtid>24285160</mtid>
          <link>/api/publicationidentifier/24285160</link>
          <label>WoS: 001037607400001</label>
          <source>
            <otype>PlainSource</otype>
            <mtid>1</mtid>
            <link>/api/publicationsource/1</link>
            <label>WoS</label>
            <type>
              <otype>PublicationSourceType</otype>
              <mtid>10003</mtid>
              <link>/api/publicationsourcetype/10003</link>
              <label>Indexelő adatbázis</label>
              <mayHaveOa>false</mayHaveOa>
              <published>true</published>
              <snippet>true</snippet>
            </type>
            <name>WoS</name>
            <nameEng>WoS</nameEng>
            <linkPattern>https://www.webofscience.com/wos/woscc/full-record/@@@</linkPattern>
            <publiclyVisible>true</publiclyVisible>
            <published>true</published>
            <oldId>1</oldId>
            <snippet>true</snippet>
          </source>
          <validState>IDENTICAL</validState>
          <idValue>001037607400001</idValue>
          <realUrl>https://www.webofscience.com/wos/woscc/full-record/001037607400001</realUrl>
          <published>false</published>
          <snippet>true</snippet>
        </identifier>
        <identifier>
          <otype>PublicationIdentifier</otype>
          <mtid>24417771</mtid>
          <link>/api/publicationidentifier/24417771</link>
          <label>REAL: 172648</label>
          <source>
            <otype>SwordSource</otype>
            <mtid>36</mtid>
            <link>/api/publicationsource/36</link>
            <label>REAL</label>
            <type>
              <otype>PublicationSourceType</otype>
              <mtid>10007</mtid>
              <link>/api/publicationsourcetype/10007</link>
              <label>Repozitórium</label>
              <mayHaveOa>true</mayHaveOa>
              <published>true</published>
              <snippet>true</snippet>
            </type>
            <name>REAL</name>
            <nameEng>REAL</nameEng>
            <linkPattern>https://real.mtak.hu/@@@</linkPattern>
            <publiclyVisible>true</publiclyVisible>
            <published>true</published>
            <oldId>36</oldId>
            <snippet>true</snippet>
          </source>
          <oaType>GREEN</oaType>
          <oaFree>true</oaFree>
          <idValue>172648</idValue>
          <realUrl>https://real.mtak.hu/172648</realUrl>
          <published>false</published>
          <snippet>true</snippet>
        </identifier>
        <identifier>
          <otype>PublicationIdentifier</otype>
          <mtid>24549750</mtid>
          <link>/api/publicationidentifier/24549750</link>
          <label>Scopus: 85166405012</label>
          <source>
            <otype>PlainSource</otype>
            <mtid>3</mtid>
            <link>/api/publicationsource/3</link>
            <label>Scopus</label>
            <type>
              <otype>PublicationSourceType</otype>
              <mtid>10003</mtid>
              <link>/api/publicationsourcetype/10003</link>
              <label>Indexelő adatbázis</label>
              <mayHaveOa>false</mayHaveOa>
              <published>true</published>
              <snippet>true</snippet>
            </type>
            <name>Scopus</name>
            <nameEng>Scopus</nameEng>
            <linkPattern>http://www.scopus.com/record/display.url?origin=inward&amp;eid=2-s2.0-@@@</linkPattern>
            <publiclyVisible>true</publiclyVisible>
            <published>true</published>
            <oldId>3</oldId>
            <snippet>true</snippet>
          </source>
          <validState>IDENTICAL</validState>
          <idValue>85166405012</idValue>
          <realUrl>http://www.scopus.com/record/display.url?origin=inward&amp;eid=2-s2.0-85166405012</realUrl>
          <published>false</published>
          <snippet>true</snippet>
        </identifier>
        <identifier>
          <otype>PublicationIdentifier</otype>
          <mtid>24285161</mtid>
          <link>/api/publicationidentifier/24285161</link>
          <label>PubMed: 37515069</label>
          <source>
            <otype>PlainSource</otype>
            <mtid>17</mtid>
            <link>/api/publicationsource/17</link>
            <label>PubMed</label>
            <type>
              <otype>PublicationSourceType</otype>
              <mtid>10003</mtid>
              <link>/api/publicationsourcetype/10003</link>
              <label>Indexelő adatbázis</label>
              <mayHaveOa>false</mayHaveOa>
              <published>true</published>
              <snippet>true</snippet>
            </type>
            <name>PubMed</name>
            <nameEng>PubMed</nameEng>
            <linkPattern>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=@@@&amp;dopt=Abstract</linkPattern>
            <publiclyVisible>true</publiclyVisible>
            <published>true</published>
            <oldId>17</oldId>
            <snippet>true</snippet>
          </source>
          <validState>IDENTICAL</validState>
          <idValue>37515069</idValue>
          <realUrl>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=37515069&amp;dopt=Abstract</realUrl>
          <published>false</published>
          <snippet>true</snippet>
        </identifier>
        <identifier>
          <otype>PublicationIdentifier</otype>
          <mtid>24204746</mtid>
          <link>/api/publicationidentifier/24204746</link>
          <label>Egyéb URL: https://www.mdpi.com/2076-393X/11/7/1254</label>
          <source>
            <otype>PlainSource</otype>
            <mtid>40</mtid>
            <link>/api/publicationsource/40</link>
            <label>Egyéb URL</label>
            <type>
              <otype>PublicationSourceType</otype>
              <mtid>10006</mtid>
              <link>/api/publicationsourcetype/10006</link>
              <label>Link</label>
              <mayHaveOa>true</mayHaveOa>
              <published>true</published>
              <snippet>true</snippet>
            </type>
            <name>Egyéb URL</name>
            <nameEng>Other URL</nameEng>
            <linkPattern>@@@</linkPattern>
            <publiclyVisible>true</publiclyVisible>
            <published>true</published>
            <oldId>40</oldId>
            <snippet>true</snippet>
          </source>
          <idValue>https://www.mdpi.com/2076-393X/11/7/1254</idValue>
          <realUrl>https://www.mdpi.com/2076-393X/11/7/1254</realUrl>
          <published>false</published>
          <snippet>true</snippet>
        </identifier>
      </identifiers>
      <ratings>
        <rating>
          <otype>SjrRating</otype>
          <mtid>11370441</mtid>
          <link>/api/sjrrating/11370441</link>
          <label>sjr:Q1 (2023) Scopus - Drug Discovery VACCINES (BASEL) 2076-393X</label>
          <listPos>25</listPos>
          <rankValue>0.24</rankValue>
          <type>journal</type>
          <ratingType>
            <otype>RatingType</otype>
            <mtid>10002</mtid>
            <link>/api/ratingtype/10002</link>
            <label>sjr</label>
            <code>sjr</code>
            <published>true</published>
            <snippet>true</snippet>
          </ratingType>
          <subject>
            <otype>ClassificationExternal</otype>
            <mtid>3002</mtid>
            <link>/api/classificationexternal/3002</link>
            <label>Scopus - Drug Discovery</label>
            <published>true</published>
            <oldId>3002</oldId>
            <snippet>true</snippet>
          </subject>
          <ranking>Q1</ranking>
          <calculation>DIRECT</calculation>
          <published>true</published>
          <snippet>true</snippet>
        </rating>
      </ratings>
      <references>
        <reference>
          <otype>Reference</otype>
          <mtid>43839789</mtid>
          <link>/api/reference/43839789</link>
          <label>1. Restifo 2012: Adoptive immunotherapy for cancer: Harnessing the T cell response., Nat. Rev. Immunol., 12, p. 269, DOI: 10.1038/nri3191</label>
          <listPosition>1</listPosition>
          <doi>10.1038/nri3191</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839790</mtid>
          <link>/api/reference/43839790</link>
          <label>2. Jiang 2015: T-cell exhaustion in the tumor microenvironment., Cell Death Dis., 6, p. e1792, DOI: 10.1038/cddis.2015.162</label>
          <listPosition>2</listPosition>
          <doi>10.1038/cddis.2015.162</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839791</mtid>
          <link>/api/reference/43839791</link>
          <label>3. Zhang 2020: T Cell Dysfunction and Exhaustion in Cancer., Front. Cell Dev. Biol., 8, p. 17, DOI: 10.3389/fcell.2020.00017</label>
          <listPosition>3</listPosition>
          <doi>10.3389/fcell.2020.00017</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839792</mtid>
          <link>/api/reference/43839792</link>
          <label>4. Blasko 2010: Mechanism of tumor cell-induced T-cell apoptosis mediated by galectin-1., Immunol. Lett., 127, p. 108, DOI: 10.1016/j.imlet.2009.10.003</label>
          <listPosition>4</listPosition>
          <doi>10.1016/j.imlet.2009.10.003</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839793</mtid>
          <link>/api/reference/43839793</link>
          <label>5. Ion 2006: Acid sphingomyelinase mediated release of ceramide is essential to trigger the mitochondrial pathway of apoptosis by galectin-1., Cell Signal., 18, p. 1887, DOI: 10.1016/j.cellsig.2006.02.007</label>
          <listPosition>5</listPosition>
          <doi>10.1016/j.cellsig.2006.02.007</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839794</mtid>
          <link>/api/reference/43839794</link>
          <label>6. Blasko 2008: Co-localization of galectin-1 with GM1 ganglioside in the course of its clathrin- and raft-dependent endocytosis., Cell. Mol. Life Sci., 65, p. 2586, DOI: 10.1007/s00018-008-8143-x</label>
          <listPosition>6</listPosition>
          <doi>10.1007/s00018-008-8143-x</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839795</mtid>
          <link>/api/reference/43839795</link>
          <label>7. Li 2020: Regulatory T cells in tumor microenvironment: New mechanisms, potential therapeutic strategies and future prospects., Mol. Cancer, 19, p. 116, DOI: 10.1186/s12943-020-01234-1</label>
          <listPosition>7</listPosition>
          <doi>10.1186/s12943-020-01234-1</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839796</mtid>
          <link>/api/reference/43839796</link>
          <label>8. Scott 2021: Regulatory T Cells: Barriers of Immune Infiltration Into the Tumor Microenvironment., Front. Immunol., 12, p. 702726, DOI: 10.3389/fimmu.2021.702726</label>
          <listPosition>8</listPosition>
          <doi>10.3389/fimmu.2021.702726</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839797</mtid>
          <link>/api/reference/43839797</link>
          <label>9. Devillier 2021: Mechanisms of NK cell dysfunction in the tumor microenvironment and current clinical approaches to harness NK cell potential for immunotherapy., J. Leukoc. Biol., 109, p. 1071, DOI: 10.1002/JLB.5MR0920-198RR</label>
          <listPosition>9</listPosition>
          <doi>10.1002/JLB.5MR0920-198RR</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839798</mtid>
          <link>/api/reference/43839798</link>
          <label>10. Zhang 2022: Natural killer cell dysfunction in cancer and new strategies to utilize NK cell potential for cancer immunotherapy., Mol. Immunol., 144, p. 58, DOI: 10.1016/j.molimm.2022.02.015</label>
          <listPosition>10</listPosition>
          <doi>10.1016/j.molimm.2022.02.015</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839799</mtid>
          <link>/api/reference/43839799</link>
          <label>11. Strauss 2015: RORC1 Regulates Tumor-Promoting "Emergency" Granulo-Monocytopoiesis., Cancer Cell, 28, p. 253, DOI: 10.1016/j.ccell.2015.07.006</label>
          <listPosition>11</listPosition>
          <doi>10.1016/j.ccell.2015.07.006</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839800</mtid>
          <link>/api/reference/43839800</link>
          <label>12. Hegde 2021: MDSC: Markers, development, states, and unaddressed complexity., Immunity, 54, p. 875, DOI: 10.1016/j.immuni.2021.04.004</label>
          <listPosition>12</listPosition>
          <doi>10.1016/j.immuni.2021.04.004</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839801</mtid>
          <link>/api/reference/43839801</link>
          <label>13. Szebeni, G.J., Vizler, C., Nagy, L.I., Kitajka, K., and Puskas, L.G. (2016). Pro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic Targets. Int. J. Mol. Sci., 17., DOI: 10.3390/ijms17111958</label>
          <listPosition>13</listPosition>
          <doi>10.3390/ijms17111958</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839802</mtid>
          <link>/api/reference/43839802</link>
          <label>14. Szebeni 2017: Inflammation and Cancer: Extra- and Intracellular Determinants of Tumor-Associated Macrophages as Tumor Promoters., Mediat. Inflamm., 2017, p. 9294018, DOI: 10.1155/2017/9294018</label>
          <listPosition>14</listPosition>
          <doi>10.1155/2017/9294018</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839803</mtid>
          <link>/api/reference/43839803</link>
          <label>15. Taylor 2022: Mechanisms of MHC-I Downregulation and Role in Immunotherapy Response., Front. Immunol., 13, p. 844866, DOI: 10.3389/fimmu.2022.844866</label>
          <listPosition>15</listPosition>
          <doi>10.3389/fimmu.2022.844866</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839804</mtid>
          <link>/api/reference/43839804</link>
          <label>16. Escors 2014: Tumour immunogenicity, antigen presentation and immunological barriers in cancer immunotherapy., New J. Sci., 2014, p. 734515, DOI: 10.1155/2014/734515</label>
          <listPosition>16</listPosition>
          <doi>10.1155/2014/734515</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839805</mtid>
          <link>/api/reference/43839805</link>
          <label>17. Zagorulya 2020: Impact of anatomic site on antigen-presenting cells in cancer., J. Immunother. Cancer, 8, p. e001204, DOI: 10.1136/jitc-2020-001204</label>
          <listPosition>17</listPosition>
          <doi>10.1136/jitc-2020-001204</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839806</mtid>
          <link>/api/reference/43839806</link>
          <label>18. Jeong 2020: Co-Stimulatory Receptors in Cancers and Their Implications for Cancer Immunotherapy., Immune Netw., 20, p. e3, DOI: 10.4110/in.2020.20.e3</label>
          <listPosition>18</listPosition>
          <doi>10.4110/in.2020.20.e3</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839807</mtid>
          <link>/api/reference/43839807</link>
          <label>19. Tan 2022: The role of B cells in cancer development., Front. Oncol., 12, p. 958756, DOI: 10.3389/fonc.2022.958756</label>
          <listPosition>19</listPosition>
          <doi>10.3389/fonc.2022.958756</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839808</mtid>
          <link>/api/reference/43839808</link>
          <label>20. Wu 2022: B cell deficiency promotes the initiation and progression of lung cancer., Front. Oncol., 12, p. 1006477, DOI: 10.3389/fonc.2022.1006477</label>
          <listPosition>20</listPosition>
          <doi>10.3389/fonc.2022.1006477</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839809</mtid>
          <link>/api/reference/43839809</link>
          <label>21. Balog, J.A., Hackler, L., Kovacs, A.K., Neuperger, P., Alfoldi, R., Nagy, L.I., Puskas, L.G., and Szebeni, G.J. (2019). Single Cell Mass Cytometry Revealed the Immunomodulatory Effect of Cisplatin Via Downregulation of Splenic CD44+, IL-17A+ MDSCs and Promotion of Circulating IFN-gamma+ Myeloid Cells in the 4T1 Metastatic Breast Cancer Model. Int. J. Mol. Sci., 21., DOI: 10.3390/ijms21010170</label>
          <listPosition>21</listPosition>
          <doi>10.3390/ijms21010170</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839810</mtid>
          <link>/api/reference/43839810</link>
          <label>22. Kerr 2019: The Next Generation of Immunotherapy for Cancer: Small Molecules Could Make Big Waves., J. Immunol., 202, p. 11, DOI: 10.4049/jimmunol.1800991</label>
          <listPosition>22</listPosition>
          <doi>10.4049/jimmunol.1800991</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839811</mtid>
          <link>/api/reference/43839811</link>
          <label>23. Wu 2022: Small molecule-based immunomodulators for cancer therapy., Acta Pharm. Sin. B, 12, p. 4287, DOI: 10.1016/j.apsb.2022.11.007</label>
          <listPosition>23</listPosition>
          <doi>10.1016/j.apsb.2022.11.007</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839812</mtid>
          <link>/api/reference/43839812</link>
          <label>24. Borghaei 2015: Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer., N. Engl. J. Med., 373, p. 1627, DOI: 10.1056/NEJMoa1507643</label>
          <listPosition>24</listPosition>
          <doi>10.1056/NEJMoa1507643</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839813</mtid>
          <link>/api/reference/43839813</link>
          <label>25. Brahmer 2015: Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer., N. Engl. J. Med., 373, p. 123, DOI: 10.1056/NEJMoa1504627</label>
          <listPosition>25</listPosition>
          <doi>10.1056/NEJMoa1504627</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839814</mtid>
          <link>/api/reference/43839814</link>
          <label>26. Herbst 2016: Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): A randomised controlled trial., Lancet, 387, p. 1540, DOI: 10.1016/S0140-6736(15)01281-7</label>
          <listPosition>26</listPosition>
          <doi>10.1016/S0140-6736(15)01281-7</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839815</mtid>
          <link>/api/reference/43839815</link>
          <label>27. Hopkins 2018: T cell receptor repertoire features associated with survival in immunotherapy-treated pancreatic ductal adenocarcinoma., JCI Insight, 3, p. e122092, DOI: 10.1172/jci.insight.122092</label>
          <listPosition>27</listPosition>
          <doi>10.1172/jci.insight.122092</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839816</mtid>
          <link>/api/reference/43839816</link>
          <label>28. Tumeh 2014: PD-1 blockade induces responses by inhibiting adaptive immune resistance., Nature, 515, p. 568, DOI: 10.1038/nature13954</label>
          <listPosition>28</listPosition>
          <doi>10.1038/nature13954</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839817</mtid>
          <link>/api/reference/43839817</link>
          <label>29. Shiravand 2022: Immune Checkpoint Inhibitors in Cancer Therapy., Curr. Oncol., 29, p. 3044, DOI: 10.3390/curroncol29050247</label>
          <listPosition>29</listPosition>
          <doi>10.3390/curroncol29050247</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839818</mtid>
          <link>/api/reference/43839818</link>
          <label>30. Tan 2022: Immune Checkpoint Inhibitor Therapy in Oncology: Current Uses and Future Directions: JACC: CardioOncology State-of-the-Art Review., JACC CardioOncol., 4, p. 579, DOI: 10.1016/j.jaccao.2022.09.004</label>
          <listPosition>30</listPosition>
          <doi>10.1016/j.jaccao.2022.09.004</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839819</mtid>
          <link>/api/reference/43839819</link>
          <label>31. Alnefaie 2022: Chimeric Antigen Receptor T-Cells: An Overview of Concepts, Applications, Limitations, and Proposed Solutions., Front. Bioeng. Biotechnol., 10, p. 797440, DOI: 10.3389/fbioe.2022.797440</label>
          <listPosition>31</listPosition>
          <doi>10.3389/fbioe.2022.797440</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839820</mtid>
          <link>/api/reference/43839820</link>
          <label>32. Yan 2023: Current advances and challenges in CAR T-Cell therapy for solid tumors: Tumor-associated antigens and the tumor microenvironment., Exp. Hematol. Oncol., 12, p. 14, DOI: 10.1186/s40164-023-00373-7</label>
          <listPosition>32</listPosition>
          <doi>10.1186/s40164-023-00373-7</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839821</mtid>
          <link>/api/reference/43839821</link>
          <label>33. Zhang 2022: CAR-NK cells for cancer immunotherapy: From bench to bedside., Biomark. Res., 10, p. 12, DOI: 10.1186/s40364-022-00364-6</label>
          <listPosition>33</listPosition>
          <doi>10.1186/s40364-022-00364-6</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839822</mtid>
          <link>/api/reference/43839822</link>
          <label>34. Circelli 2017: Use of adjuvants for immunotherapy., Hum. Vaccin Immunother., 13, p. 1774, DOI: 10.1080/21645515.2017.1321725</label>
          <listPosition>34</listPosition>
          <doi>10.1080/21645515.2017.1321725</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839823</mtid>
          <link>/api/reference/43839823</link>
          <label>35. Diao, L., and Liu, M. (2023). Rethinking Antigen Source: Cancer Vaccines Based on Whole Tumor Cell/tissue Lysate or Whole Tumor Cell. Adv. Sci., e2300121., DOI: 10.1002/advs.202300121</label>
          <listPosition>35</listPosition>
          <doi>10.1002/advs.202300121</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839824</mtid>
          <link>/api/reference/43839824</link>
          <label>36. Chen 2022: Autologous whole-cell cancer vaccination: Cryogenic silicified vaccines., Matter UK, 5, p. 2434, DOI: 10.1016/j.matt.2022.05.025</label>
          <listPosition>36</listPosition>
          <doi>10.1016/j.matt.2022.05.025</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839825</mtid>
          <link>/api/reference/43839825</link>
          <label>37. Najafabadi 2022: Tumor cell-based vaccine: An effective strategy for eradication of cancer cells., Immunother. UK, 14, p. 639, DOI: 10.2217/imt-2022-0036</label>
          <listPosition>37</listPosition>
          <doi>10.2217/imt-2022-0036</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839826</mtid>
          <link>/api/reference/43839826</link>
          <label>38. Liu 2022: Cancer vaccines as promising immuno-therapeutics: Platforms and current progress., J. Hematol. Oncol., 15, p. 28, DOI: 10.1186/s13045-022-01247-x</label>
          <listPosition>38</listPosition>
          <doi>10.1186/s13045-022-01247-x</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839827</mtid>
          <link>/api/reference/43839827</link>
          <label>39. Lin 2022: Cancer vaccines: The next immunotherapy frontier., Nat. Cancer, 3, p. 911, DOI: 10.1038/s43018-022-00418-6</label>
          <listPosition>39</listPosition>
          <doi>10.1038/s43018-022-00418-6</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839828</mtid>
          <link>/api/reference/43839828</link>
          <label>40. Grimmett 2022: Cancer vaccines: Past, present and future; a review article., Discov. Oncol., 13, p. 31, DOI: 10.1007/s12672-022-00491-4</label>
          <listPosition>40</listPosition>
          <doi>10.1007/s12672-022-00491-4</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839829</mtid>
          <link>/api/reference/43839829</link>
          <label>41. Hu 2020: Emerging Adjuvants for Cancer Immunotherapy., Front. Chem., 8, p. 601, DOI: 10.3389/fchem.2020.00601</label>
          <listPosition>41</listPosition>
          <doi>10.3389/fchem.2020.00601</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839830</mtid>
          <link>/api/reference/43839830</link>
          <label>42. Cuzzubbo 2020: Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments., Front. Immunol., 11, p. 615240, DOI: 10.3389/fimmu.2020.615240</label>
          <listPosition>42</listPosition>
          <doi>10.3389/fimmu.2020.615240</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839831</mtid>
          <link>/api/reference/43839831</link>
          <label>43. Zhang 2023: Materials engineering strategies for cancer vaccine adjuvant development., Chem. Soc. Rev., 52, p. 2886, DOI: 10.1039/D2CS00647B</label>
          <listPosition>43</listPosition>
          <doi>10.1039/D2CS00647B</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839832</mtid>
          <link>/api/reference/43839832</link>
          <label>44. Stronen 2016: Targeting of cancer neoantigens with donor-derived T cell receptor repertoires., Science, 352, p. 1337, DOI: 10.1126/science.aaf2288</label>
          <listPosition>44</listPosition>
          <doi>10.1126/science.aaf2288</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839833</mtid>
          <link>/api/reference/43839833</link>
          <label>45. Matera 2009: Cross-presentation of tumor antigens is increased by UVC light tumor treatment., Clin. Cancer Res., 15, p. 7447, DOI: 10.1158/1078-0432.CCR-09-2117</label>
          <listPosition>45</listPosition>
          <doi>10.1158/1078-0432.CCR-09-2117</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839834</mtid>
          <link>/api/reference/43839834</link>
          <label>46. Gorelik 1991: Effect of ultraviolet irradiation on MCA102 tumor cell immunogenicity and sensitivity to tumor necrosis factor., Cancer Res., 51, p. 1521</label>
          <listPosition>46</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839835</mtid>
          <link>/api/reference/43839835</link>
          <label>47. Gullo 2008: Use of ultraviolet-light irradiated multiple myeloma cells as immunogens to generate tumor-specific cytolytic T lymphocytes., J. Immune Based Ther. Vaccines, 6, p. 2, DOI: 10.1186/1476-8518-6-2</label>
          <listPosition>47</listPosition>
          <doi>10.1186/1476-8518-6-2</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839836</mtid>
          <link>/api/reference/43839836</link>
          <label>48. Chiang 2015: Whole Tumor Antigen Vaccines: Where Are We?., Vaccines, 3, p. 344, DOI: 10.3390/vaccines3020344</label>
          <listPosition>48</listPosition>
          <doi>10.3390/vaccines3020344</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839837</mtid>
          <link>/api/reference/43839837</link>
          <label>49. Zhang 2003: CpG ODN 2006 and IL-12 are comparable for priming Th1 lymphocyte and IgG responses in cattle immunized with a rickettsial outer membrane protein in alum., Vaccine, 21, p. 3307, DOI: 10.1016/S0264-410X(03)00176-2</label>
          <listPosition>49</listPosition>
          <doi>10.1016/S0264-410X(03)00176-2</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839838</mtid>
          <link>/api/reference/43839838</link>
          <label>50. Conforti 2007: The effectiveness of a CpG motif-based adjuvant (CpG ODN 2006) for LHRH immunization., Vaccine, 25, p. 6537, DOI: 10.1016/j.vaccine.2007.05.056</label>
          <listPosition>50</listPosition>
          <doi>10.1016/j.vaccine.2007.05.056</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839839</mtid>
          <link>/api/reference/43839839</link>
          <label>51. Szebeni, G.J., Balog, J.A., Demjen, A., Alfoldi, R., Vegi, V.L., Feher, L.Z., Man, I., Kotogany, E., Guban, B., and Batar, P. (2018). Imidazo[1,2-b]pyrazole-7-carboxamides Induce Apoptosis in Human Leukemia Cells at Nanomolar Concentrations. Molecules, 23., DOI: 10.3390/molecules23112845</label>
          <listPosition>51</listPosition>
          <doi>10.3390/molecules23112845</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839840</mtid>
          <link>/api/reference/43839840</link>
          <label>52. Demjen 2018: Synthesis, cytotoxic characterization, and SAR study of imidazo[1,2-b]pyrazole-7-carboxamides., Arch. Pharm., 351, p. e1800062, DOI: 10.1002/ardp.201800062</label>
          <listPosition>52</listPosition>
          <doi>10.1002/ardp.201800062</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839841</mtid>
          <link>/api/reference/43839841</link>
          <label>53. Gemes 2022: A cytotoxic survey on 2-amino-1H-imidazol based synthetic marine sponge alkaloid analogues., Drug Dev. Res., 83, p. 1906, DOI: 10.1002/ddr.22006</label>
          <listPosition>53</listPosition>
          <doi>10.1002/ddr.22006</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839842</mtid>
          <link>/api/reference/43839842</link>
          <label>54. Kulmany 2021: Biological evaluation of antiproliferative and anti-invasive properties of an androstadiene derivative on human cervical cancer cell lines., J. Steroid Biochem. Mol. Biol., 214, p. 105990, DOI: 10.1016/j.jsbmb.2021.105990</label>
          <listPosition>54</listPosition>
          <doi>10.1016/j.jsbmb.2021.105990</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839843</mtid>
          <link>/api/reference/43839843</link>
          <label>55. Szebeni, G.J., Kriston-Pal, E., Blazso, P., Katona, R.L., Novak, J., Szabo, E., Czibula, A., Fajka-Boja, R., Hegyi, B., and Uher, F. (2012). Identification of galectin-1 as a critical factor in function of mouse mesenchymal stromal cell-mediated tumor promotion. PLoS ONE, 7., DOI: 10.1371/journal.pone.0041372</label>
          <listPosition>55</listPosition>
          <doi>10.1371/journal.pone.0041372</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839844</mtid>
          <link>/api/reference/43839844</link>
          <label>56. Puskas 2016: Novel Anti-CRR9/CLPTM1L Antibodies with Antitumorigenic Activity Inhibit Cell Surface Accumulation, PI3K Interaction, and Survival Signaling., Mol. Cancer Ther., 15, p. 985, DOI: 10.1158/1535-7163.MCT-15-0717</label>
          <listPosition>56</listPosition>
          <doi>10.1158/1535-7163.MCT-15-0717</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839845</mtid>
          <link>/api/reference/43839845</link>
          <label>57. Neuperger, P., Balog, J.A., Tiszlavicz, L., Furak, J., Gemes, N., Kotogany, E., Szalontai, K., Puskas, L.G., and Szebeni, G.J. (2021). Analysis of the Single-Cell Heterogeneity of Adenocarcinoma Cell Lines and the Investigation of Intratumor Heterogeneity Reveals the Expression of Transmembrane Protein 45A (TMEM45A) in Lung Adenocarcinoma Cancer Patients. Cancers, 14., DOI: 10.3390/cancers14010144</label>
          <listPosition>57</listPosition>
          <doi>10.3390/cancers14010144</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839846</mtid>
          <link>/api/reference/43839846</link>
          <label>58. Liu 2019: Epithelial-type systemic breast carcinoma cells with a restricted mesenchymal transition are a major source of metastasis., Sci. Adv., 5, p. eaav4275, DOI: 10.1126/sciadv.aav4275</label>
          <listPosition>58</listPosition>
          <doi>10.1126/sciadv.aav4275</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839847</mtid>
          <link>/api/reference/43839847</link>
          <label>59. Takai 2016: Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer., Oncotarget, 7, p. 82889, DOI: 10.18632/oncotarget.12658</label>
          <listPosition>59</listPosition>
          <doi>10.18632/oncotarget.12658</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839848</mtid>
          <link>/api/reference/43839848</link>
          <label>60. Hicks 2006: Transferable anticancer innate immunity in spontaneous regression/complete resistance mice., Proc. Natl. Acad. Sci. USA, 103, p. 7753, DOI: 10.1073/pnas.0602382103</label>
          <listPosition>60</listPosition>
          <doi>10.1073/pnas.0602382103</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839849</mtid>
          <link>/api/reference/43839849</link>
          <label>61. Carmi 2015: Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity., Nature, 521, p. 99, DOI: 10.1038/nature14424</label>
          <listPosition>61</listPosition>
          <doi>10.1038/nature14424</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839850</mtid>
          <link>/api/reference/43839850</link>
          <label>62. Macagno 2019: NK-mediated antibody-dependent cell-mediated cytotoxicity in solid tumors: Biological evidence and clinical perspectives., Ann. Transl. Med., 7, p. 105, DOI: 10.21037/atm.2019.01.42</label>
          <listPosition>62</listPosition>
          <doi>10.21037/atm.2019.01.42</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839851</mtid>
          <link>/api/reference/43839851</link>
          <label>63. Morotti 2021: Promises and challenges of adoptive T-cell therapies for solid tumours., Br. J. Cancer, 124, p. 1759, DOI: 10.1038/s41416-021-01353-6</label>
          <listPosition>63</listPosition>
          <doi>10.1038/s41416-021-01353-6</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839852</mtid>
          <link>/api/reference/43839852</link>
          <label>64. Li 2011: Adoptive transfer of tumor reactive B cells confers host T-cell immunity and tumor regression., Clin. Cancer Res., 17, p. 4987, DOI: 10.1158/1078-0432.CCR-11-0207</label>
          <listPosition>64</listPosition>
          <doi>10.1158/1078-0432.CCR-11-0207</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839853</mtid>
          <link>/api/reference/43839853</link>
          <label>65. Bracci 2007: Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration., Clin. Cancer Res., 13, p. 644, DOI: 10.1158/1078-0432.CCR-06-1209</label>
          <listPosition>65</listPosition>
          <doi>10.1158/1078-0432.CCR-06-1209</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839854</mtid>
          <link>/api/reference/43839854</link>
          <label>66. Hughes 2018: T-cell modulation by cyclophosphamide for tumour therapy., Immunology, 154, p. 62, DOI: 10.1111/imm.12913</label>
          <listPosition>66</listPosition>
          <doi>10.1111/imm.12913</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839855</mtid>
          <link>/api/reference/43839855</link>
          <label>67. Luznik 2010: High-dose cyclophosphamide for graft-versus-host disease prevention., Curr. Opin. Hematol., 17, p. 493, DOI: 10.1097/MOH.0b013e32833eaf1b</label>
          <listPosition>67</listPosition>
          <doi>10.1097/MOH.0b013e32833eaf1b</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839856</mtid>
          <link>/api/reference/43839856</link>
          <label>68. Nash 2022: Clinically translatable cytokine delivery platform for eradication of intraperitoneal tumors., Sci. Adv., 8, p. eabm1032, DOI: 10.1126/sciadv.abm1032</label>
          <listPosition>68</listPosition>
          <doi>10.1126/sciadv.abm1032</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839857</mtid>
          <link>/api/reference/43839857</link>
          <label>69. West 2013: PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells., J. Clin. Investig., 123, p. 2604, DOI: 10.1172/JCI67008</label>
          <listPosition>69</listPosition>
          <doi>10.1172/JCI67008</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839858</mtid>
          <link>/api/reference/43839858</link>
          <label>70. Schwaab 2009: Clinical and immunologic effects of intranodal autologous tumor lysate-dendritic cell vaccine with Aldesleukin (Interleukin 2) and IFN-alpha2a therapy in metastatic renal cell carcinoma patients., Clin. Cancer Res., 15, p. 4986, DOI: 10.1158/1078-0432.CCR-08-3240</label>
          <listPosition>70</listPosition>
          <doi>10.1158/1078-0432.CCR-08-3240</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839859</mtid>
          <link>/api/reference/43839859</link>
          <label>71. Saberian, C., Amaria, R.N., Najjar, A.M., Radvanyi, L.G., Haymaker, C.L., Forget, M.A., Bassett, R.L., Faria, S.C., Glitza, I.C., and Alvarez, E. (2021). Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma. J. Immunother. Cancer, 9., DOI: 10.1136/jitc-2021-002449</label>
          <listPosition>71</listPosition>
          <doi>10.1136/jitc-2021-002449</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839860</mtid>
          <link>/api/reference/43839860</link>
          <label>72. Flesner 2020: Autologous cancer cell vaccination, adoptive T-cell transfer, and interleukin-2 administration results in long-term survival for companion dogs with osteosarcoma., J. Vet. Intern. Med., 34, p. 2056, DOI: 10.1111/jvim.15852</label>
          <listPosition>72</listPosition>
          <doi>10.1111/jvim.15852</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839861</mtid>
          <link>/api/reference/43839861</link>
          <label>73. Reilley 2019: TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma., J. Immunother. Cancer, 7, p. 323, DOI: 10.1186/s40425-019-0811-x</label>
          <listPosition>73</listPosition>
          <doi>10.1186/s40425-019-0811-x</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839862</mtid>
          <link>/api/reference/43839862</link>
          <label>74. Arrieta, A., Galvis, A.E., Osborne, S., Morphew, T., Imfeld, K., Enriquez, C., Hoang, J., Swearingen, M., Nieves, D.J., and Ashouri, N. (2023). Use of COVID-19 Convalescent Plasma for Treatment of Symptomatic SARS-CoV-2 Infection at a Children’s Hospital: A Contribution to a Still Inadequate Body of Evidence. Children, 10., DOI: 10.3390/children10020350</label>
          <listPosition>74</listPosition>
          <doi>10.3390/children10020350</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839863</mtid>
          <link>/api/reference/43839863</link>
          <label>75. Marconato 2022: Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response., J. Clin. Investig., 132, p. e158190, DOI: 10.1172/JCI158190</label>
          <listPosition>75</listPosition>
          <doi>10.1172/JCI158190</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>43839864</mtid>
          <link>/api/reference/43839864</link>
          <label>76. Waldman 2020: A guide to cancer immunotherapy: From T cell basic science to clinical practice., Nat. Rev. Immunol., 20, p. 651, DOI: 10.1038/s41577-020-0306-5</label>
          <listPosition>76</listPosition>
          <doi>10.1038/s41577-020-0306-5</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
      </references>
      <link>/api/publication/34076543</link>
      <label>Szebeni Gábor J. et al. Introduction of an Ultraviolet C-Irradiated 4T1 Murine Breast Cancer Whole-Cell Vaccine Model. (2023) VACCINES (BASEL) 2076-393X 11 7</label><template>&lt;div class=&quot;JournalArticle Publication short-list&quot;&gt; &lt;div class=&quot;authors&quot;&gt; &lt;span class=&quot;author-name&quot; mtid=&quot;10025339&quot;&gt; &lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10025339&quot; target=&quot;_blank&quot;&gt;Szebeni, Gábor J. ✉&lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; &gt; Alföldi, Róbert &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; &gt; Nagy, Lajos I. &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; mtid=&quot;10071441&quot;&gt; &lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10071441&quot; target=&quot;_blank&quot;&gt;Neuperger, Patrícia&lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; mtid=&quot;10081633&quot;&gt; &lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10081633&quot; target=&quot;_blank&quot;&gt;Gémes, Nikolett&lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; mtid=&quot;10065273&quot;&gt; &lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10065273&quot; target=&quot;_blank&quot;&gt;Balog, József Á.&lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; mtid=&quot;10009640&quot;&gt; &lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10009640&quot; target=&quot;_blank&quot;&gt;Tiszlavicz, László&lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; mtid=&quot;10010041&quot;&gt; &lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10010041&quot; target=&quot;_blank&quot;&gt;Puskás, László G. ✉&lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; &lt;/div &gt;&lt;div class=&quot;title&quot;&gt;&lt;a href=&quot;/gui2/?mode=browse&amp;params=publication;34076543&quot; mtid=&quot;34076543&quot; target=&quot;_blank&quot;&gt;Introduction of an Ultraviolet C-Irradiated 4T1 Murine Breast Cancer Whole-Cell Vaccine Model&lt;/a&gt;&lt;/div&gt; &lt;div class=&quot;pub-info&quot;&gt; &lt;span class=&quot;journal-title&quot;&gt;VACCINES (BASEL)&lt;/span&gt; &lt;span class=&quot;journal-volume&quot;&gt;11&lt;/span&gt; : &lt;span class=&quot;journal-issue&quot;&gt;7&lt;/span&gt; &lt;span class=&quot;page&quot;&gt; Paper: 1254 , 18 p. &lt;/span&gt; &lt;span class=&quot;year&quot;&gt;(2023)&lt;/span&gt; &lt;/div&gt; &lt;div class=&quot;pub-end&quot;&gt;&lt;div class=&quot;identifier-list&quot;&gt; &lt;span class=&quot;identifiers&quot;&gt; &lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;10.3390/vaccines11071254&quot; target=&quot;_blank&quot; href=&quot;https://doi.org/10.3390/vaccines11071254&quot;&gt; DOI &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;001037607400001&quot; target=&quot;_blank&quot; href=&quot;https://www.webofscience.com/wos/woscc/full-record/001037607400001&quot;&gt; WoS &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;id identifier oa_GREEN&quot; title=&quot; Green &quot;&gt; &lt;a style=&quot;color:black&quot; title=&quot;172648&quot; target=&quot;_blank&quot; href=&quot;https://real.mtak.hu/172648&quot;&gt; REAL &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;85166405012&quot; target=&quot;_blank&quot; href=&quot;http://www.scopus.com/record/display.url?origin=inward&amp;eid=2-s2.0-85166405012&quot;&gt; Scopus &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;37515069&quot; target=&quot;_blank&quot; href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=37515069&amp;dopt=Abstract&quot;&gt; PubMed &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt; &lt;a style=&quot;color:black&quot; title=&quot;https://www.mdpi.com/2076-393X/11/7/1254&quot; target=&quot;_blank&quot; href=&quot;https://www.mdpi.com/2076-393X/11/7/1254&quot;&gt; Egyéb URL &lt;/a&gt; &lt;/span&gt; &lt;/span&gt; &lt;/div&gt; &lt;div class=&quot;short-pub-prop-list&quot;&gt; &lt;span class=&quot;deleted-record&quot;&gt;Központi kezelésű&lt;/span&gt; &lt;span class=&quot;short-pub-mtid&quot;&gt; Közlemény:34076543 &lt;/span&gt; &lt;span class=&quot;status-holder&quot;&gt;&lt;span class=&quot;status-data status-VALIDATED&quot;&gt; Egyeztetett &lt;/span&gt;&lt;/span&gt; &lt;span class=&quot;pub-core&quot;&gt;Forrás Idéző &lt;/span&gt; &lt;span class=&quot;pub-type&quot;&gt;Folyóiratcikk (Szakcikk ) &lt;/span&gt; &lt;!-- &amp;&amp; !record.category.scientific --&gt; &lt;span class=&quot;pub-category&quot;&gt;Tudományos&lt;/span&gt; &lt;div class=&quot;publication-citation&quot; style=&quot;margin-left: 0.5cm;&quot;&gt; &lt;span title=&quot;Nyilvános idézőközlemények összesen, említések nélkül&quot; class=&quot;citingPub-count&quot;&gt;Nyilvános idéző összesen: 9&lt;/span&gt; | Független: 7 | Függő: 2 | Nem jelölt: 0 | WoS jelölt: 8 | Scopus jelölt:&amp;nbsp;9 | WoS/Scopus jelölt:&amp;nbsp;9 | DOI jelölt:&amp;nbsp;9 &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;</template><template2>&lt;div class=&quot;JournalArticle Publication long-list&quot;&gt;
&lt;div class=&quot;authors&quot;&gt;
	&lt;img title=&quot;Forrásközlemény&quot; style=&quot;float: left&quot; src=&quot;/frontend/resources/grid/publication-core-icon.png&quot;&gt;
	&lt;img title=&quot;Idézőközlemény&quot; style=&quot;float: left&quot; src=&quot;/frontend/resources/grid/publication-citation-icon.png&quot;&gt;

		&lt;div class=&quot;autype autype0&quot;&gt;				&lt;span class=&quot;author-name&quot; mtid=&quot;10025339&quot;&gt;&lt;a 
																				   href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10025339&quot; target=&quot;_blank&quot;&gt;Szebeni Gábor J. ✉
            (&lt;span class=&quot;authorship-author-name&quot;&gt;Szebeni Gábor&lt;/span&gt;
            &lt;span class=&quot;authorAux-mtmt&quot;&gt; Immunológia&lt;/span&gt;)
			&lt;/a&gt;
    &lt;/span&gt;
&lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;Szegedi Biológiai Kutatóközpont&quot;&gt;SZBK&lt;/span&gt;/Genetikai Intézet; &lt;span title=&quot;Szegedi Biológiai Kutatóközpont&quot;&gt;SZBK&lt;/span&gt;/Központi Laboratóriumok; &lt;span title=&quot;Szegedi Tudományegyetem&quot;&gt;SZTE&lt;/span&gt;/&lt;span title=&quot;Természettudományi és Informatikai Kar&quot;&gt;TTIK&lt;/span&gt;/&lt;span title=&quot;Biológia Intézet&quot;&gt;BI&lt;/span&gt;/Élettani, Szervezettani és Idegtudományi Tanszék&lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; &gt;Alföldi Róbert
    &lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; &gt;Nagy Lajos I.
    &lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; mtid=&quot;10071441&quot;&gt;&lt;a 
																				   href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10071441&quot; target=&quot;_blank&quot;&gt;Neuperger Patrícia
            (&lt;span class=&quot;authorship-author-name&quot;&gt;Neuperger Patricia&lt;/span&gt;
            &lt;span class=&quot;authorAux-mtmt&quot;&gt; immunológia&lt;/span&gt;)
			&lt;/a&gt;
    &lt;/span&gt;
&lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;Szegedi Biológiai Kutatóközpont&quot;&gt;SZBK&lt;/span&gt;/Genetikai Intézet; &lt;span title=&quot;Szegedi Biológiai Kutatóközpont&quot;&gt;SZBK&lt;/span&gt;/Központi Laboratóriumok&lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; mtid=&quot;10081633&quot;&gt;&lt;a 
																				   href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10081633&quot; target=&quot;_blank&quot;&gt;Gémes Nikolett
            (&lt;span class=&quot;authorship-author-name&quot;&gt;Gémes Nikolett&lt;/span&gt;
            &lt;span class=&quot;authorAux-mtmt&quot;&gt; immunológia&lt;/span&gt;)
			&lt;/a&gt;
    &lt;/span&gt;
&lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;Szegedi Biológiai Kutatóközpont&quot;&gt;SZBK&lt;/span&gt;/Genetikai Intézet; &lt;span title=&quot;Szegedi Biológiai Kutatóközpont&quot;&gt;SZBK&lt;/span&gt;/Központi Laboratóriumok&lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; mtid=&quot;10065273&quot;&gt;&lt;a 
																				   href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10065273&quot; target=&quot;_blank&quot;&gt;Balog József Á.
            (&lt;span class=&quot;authorship-author-name&quot;&gt;Balog József Ágoston&lt;/span&gt;
            &lt;span class=&quot;authorAux-mtmt&quot;&gt; immunológia, sejtbiológia&lt;/span&gt;)
			&lt;/a&gt;
    &lt;/span&gt;
&lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;Szegedi Biológiai Kutatóközpont&quot;&gt;SZBK&lt;/span&gt;/Genetikai Intézet; &lt;span title=&quot;Szegedi Biológiai Kutatóközpont&quot;&gt;SZBK&lt;/span&gt;/Központi Laboratóriumok&lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; mtid=&quot;10009640&quot;&gt;&lt;a 
																				   href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10009640&quot; target=&quot;_blank&quot;&gt;Tiszlavicz László
            (&lt;span class=&quot;authorship-author-name&quot;&gt;Tiszlavicz László&lt;/span&gt;
            &lt;span class=&quot;authorAux-mtmt&quot;&gt; Pathológia&lt;/span&gt;)
			&lt;/a&gt;
    &lt;/span&gt;
&lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;Szegedi Tudományegyetem&quot;&gt;SZTE&lt;/span&gt;/&lt;span title=&quot;Szent-Györgyi Albert Orvostudományi Kar&quot;&gt;SZAOK&lt;/span&gt;/Pathologiai Intézet&lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; mtid=&quot;10010041&quot;&gt;&lt;a 
																				   href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10010041&quot; target=&quot;_blank&quot;&gt;Puskás László G. ✉
            (&lt;span class=&quot;authorship-author-name&quot;&gt;Puskás László&lt;/span&gt;
            &lt;span class=&quot;authorAux-mtmt&quot;&gt; Molekuláris biológia&lt;/span&gt;)
			&lt;/a&gt;
    &lt;/span&gt;
&lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;Szegedi Biológiai Kutatóközpont&quot;&gt;SZBK&lt;/span&gt;/Genetikai Intézet; &lt;span title=&quot;Szegedi Biológiai Kutatóközpont&quot;&gt;SZBK&lt;/span&gt;/Központi Laboratóriumok&lt;/span&gt;

				    &lt;/div&gt;
&lt;/div&gt;
&lt;div class=&quot;title&quot;&gt;&lt;a href=&quot;/gui2/?mode=browse&amp;params=publication;34076543&quot; target=&quot;_blank&quot;&gt;Introduction of an Ultraviolet C-Irradiated 4T1 Murine Breast Cancer Whole-Cell Vaccine Model&lt;/a&gt;&lt;/div&gt;    &lt;div&gt;		&lt;span class=&quot;journal-title&quot;&gt;VACCINES (BASEL)&lt;/span&gt;

        &lt;span class=&quot;journal-issn&quot;&gt;( &lt;a target=&quot;_blank&quot; href=&quot;https://portal.issn.org/resource/ISSN/2076-393X&quot;&gt;2076-393X&lt;/a&gt;)&lt;/span&gt;:
		&lt;span class=&quot;journal-volume&quot;&gt;11&lt;/span&gt; &lt;span class=&quot;journal-issue&quot;&gt;7&lt;/span&gt;
&lt;span class=&quot;page&quot;&gt;
		Paper 1254.
	 18 p. 
&lt;/span&gt;		 &lt;span class=&quot;year&quot;&gt;(2023)&lt;/span&gt;  
    &lt;/div&gt;
&lt;div class=&quot;pub-footer&quot;&gt;
    

	&lt;span class=&quot;language&quot; xmlns=&quot;http://www.w3.org/1999/html&quot;&gt;Nyelv:
			Angol
		 |  &lt;/span&gt;

	&lt;span class=&quot;identifiers&quot;&gt;
						&lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt;
							
							&lt;a style=&quot;color:blue&quot; title=&quot;10.3390/vaccines11071254&quot; target=&quot;_blank&quot; href=&quot;https://doi.org/10.3390/vaccines11071254&quot;&gt;
									DOI
							&lt;/a&gt;
						&lt;/span&gt;
						&lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt;
							
							&lt;a style=&quot;color:blue&quot; title=&quot;001037607400001&quot; target=&quot;_blank&quot; href=&quot;https://www.webofscience.com/wos/woscc/full-record/001037607400001&quot;&gt;
									WoS
							&lt;/a&gt;
						&lt;/span&gt;
						&lt;span class=&quot;id identifier oa_GREEN&quot; title=&quot;	Green
&quot;&gt;
							
							&lt;a style=&quot;color:black&quot; title=&quot;172648&quot; target=&quot;_blank&quot; href=&quot;https://real.mtak.hu/172648&quot;&gt;
									REAL
							&lt;/a&gt;
						&lt;/span&gt;
						&lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt;
							
							&lt;a style=&quot;color:blue&quot; title=&quot;85166405012&quot; target=&quot;_blank&quot; href=&quot;http://www.scopus.com/record/display.url?origin=inward&amp;eid=2-s2.0-85166405012&quot;&gt;
									Scopus
							&lt;/a&gt;
						&lt;/span&gt;
						&lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt;
							
							&lt;a style=&quot;color:blue&quot; title=&quot;37515069&quot; target=&quot;_blank&quot; href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=37515069&amp;dopt=Abstract&quot;&gt;
									PubMed
							&lt;/a&gt;
						&lt;/span&gt;
						&lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt;
							
							&lt;a style=&quot;color:black&quot; title=&quot;https://www.mdpi.com/2076-393X/11/7/1254&quot; target=&quot;_blank&quot; href=&quot;https://www.mdpi.com/2076-393X/11/7/1254&quot;&gt;
									Egyéb URL
							&lt;/a&gt;
						&lt;/span&gt;
	&lt;/span&gt;


	&lt;OnlyViewableByAuthor&gt;&lt;div class=&quot;ratings&quot;&gt;
				&lt;div class=&quot;journal-subject&quot;&gt;Folyóirat szakterülete: Scopus - Drug Discovery&amp;nbsp;&amp;nbsp;&amp;nbsp;SJR indikátor:&amp;nbsp;Q1&lt;/div&gt;
				&lt;div class=&quot;journal-subject&quot;&gt;Folyóirat szakterülete: Scopus - Infectious Diseases&amp;nbsp;&amp;nbsp;&amp;nbsp;SJR indikátor:&amp;nbsp;Q1&lt;/div&gt;
				&lt;div class=&quot;journal-subject&quot;&gt;Folyóirat szakterülete: Scopus - Pharmacology (medical)&amp;nbsp;&amp;nbsp;&amp;nbsp;SJR indikátor:&amp;nbsp;Q1&lt;/div&gt;
				&lt;div class=&quot;journal-subject&quot;&gt;Folyóirat szakterülete: Scopus - Pharmacology&amp;nbsp;&amp;nbsp;&amp;nbsp;SJR indikátor:&amp;nbsp;Q1&lt;/div&gt;
				&lt;div class=&quot;journal-subject&quot;&gt;Folyóirat szakterülete: Scopus - Immunology&amp;nbsp;&amp;nbsp;&amp;nbsp;SJR indikátor:&amp;nbsp;Q2&lt;/div&gt;
    &lt;/div&gt;&lt;/OnlyViewableByAuthor&gt;


	&lt;div class=&quot;publication-citation&quot; style=&quot;margin-left: 0.5cm;&quot;&gt;
		&lt;span title=&quot;Nyilvános idézőközlemények összesen, említések nélkül&quot; class=&quot;citingPub-count&quot;&gt;Nyilvános idéző összesen: 9&lt;/span&gt;
		| Független: 7
		| Függő: 2
		| Nem jelölt: 0
		| WoS jelölt: 8 
		|  Scopus jelölt:&amp;nbsp;9 
		|  WoS/Scopus jelölt:&amp;nbsp;9 
		|  DOI jelölt:&amp;nbsp;9 
		
	&lt;/div&gt;
    
    
	&lt;div class=&quot;publication-citation&quot;&gt;
		&lt;a target=&quot;_blank&quot; href=&quot;/api/publication?cond=citations.related;eq;34076543&amp;sort=publishedYear,desc&amp;sort=title&quot;&gt;
			Idézett közlemények száma: 14
		&lt;/a&gt;
	&lt;/div&gt;



    &lt;div class=&quot;mtid&quot;&gt;&lt;span class=&quot;long-pub-mtid&quot;&gt;Közlemény: 34076543&lt;/span&gt;
    | &lt;span class=&quot;status-data status-VALIDATED&quot;&gt; 	Egyeztetett
  &lt;/span&gt;
        
	
	
Forrás	 Idéző
	
	
    | &lt;span class=&quot;type-subtype&quot;&gt;Folyóiratcikk
			( Szakcikk
			
			)
		&lt;/span&gt;
      		| &lt;span class=&quot;pub-category&quot;&gt;Tudományos&lt;/span&gt;
	| &lt;span class=&quot;publication-sourceOfData&quot;&gt;kézi felvitel&lt;/span&gt;
&lt;/div&gt;


&lt;div class=&quot;lastModified&quot;&gt;Utolsó módosítás: 2023.10.20. 14:47 Sóki Edina (SZTE admin5)
&lt;/div&gt;


        &lt;div class=&quot;lockedBy&quot;&gt;Központi kezelésű 2024.04.03. 15:51  Vándor Andrea (VA, admin)
        &lt;/div&gt;


	&lt;pre class=&quot;comment&quot; style=&quot;margin-top: 0; margin-bottom: 0;&quot;&gt;&lt;u&gt;Megjegyzés&lt;/u&gt;: Laboratory of Functional Genomics, Biological Research Centre, Temesvári krt. 62, Szeged, H6726, Hungary            
            Department of Physiology, Anatomy and Neuroscience, Faculty of Science and Informatics, University of Szeged, Közép fasor 52, Szeged, H6726, Hungary            
            CS-Smartlab Devices Ltd., Ady E. u. 14, Kozármisleny, H7761, Hungary            
            As...&lt;/pre&gt;

&lt;/div&gt;&lt;/div&gt;</template2>
    </publication>
  </content>
</myciteResult>
